Search results for "HIV"

showing 10 items of 1527 documents

Who makes partner in Big 4 audit firms? – Evidence from Germany

2021

Abstract This study investigates who makes partner in Big 4 audit firms. Building on prior qualitative research, we conduct the first large scale study using archival data to examine the incremental importance of different individual auditor characteristics for making partner. For our analyses, we collect information on German auditors from a business-oriented social network site. We conduct a longitudinal analysis for a cohort of Big 4 senior managers and directors to identify determinants of making partner. We find that economic capital, social capital, and institutionalized cultural capital matter for making partner. Further, we find that female and foreign auditors are less likely to be…

Organizational Behavior and Human Resource ManagementInformation Systems and ManagementSociology and Political ScienceSocial networkbusiness.industryEconomic capitalAccountingAuditCultural capitalArchival researchddc:AccountingScale (social sciences)businessSocial capitalQualitative research
researchProduct

Differential Effects of Tenofovir/Emtricitabine and Abacavir/Lamivudine on Human Leukocyte Recruitment

2012

Background The association of abacavir (ABC) with cardiovascular disease has led to HIV treatment guidelines favouring the combination of tenofovir/emtricitabine (TDF/FTC) over that of ABC/lamivudine (ABC/3TC). We have analysed the effects of plasma-relevant concentrations of TDF, FTC, ABC and 3TC, individually and in clinically employed combinations, on human leukocyte accumulation. The effects of ABC, 3TC, TDF and FTC on the expression of adhesion molecules were also evaluated. Methods Interactions between human leukocytes – specifically peripheral blood polymorphonuclear or mono-nuclear cells – and human umbilical vein endothelial cells were evaluated in a flow chamber reproducing in viv…

OrganophosphonatesHIV InfectionsCD18Cell CommunicationPharmacologyEmtricitabineDeoxycytidinePeripheral blood mononuclear cellIn vivoAbacavirAntiretroviral Therapy Highly ActiveCell AdhesionLeukocytesmedicineEmtricitabineHumansPharmacology (medical)TenofovirPharmacologyCell adhesion moleculebusiness.industryAdenineEndothelial CellsLamivudineAbacavir/LamivudineDideoxynucleosidesDrug CombinationsInfectious DiseasesLamivudinebusinessCell Adhesion Moleculesmedicine.drugAntiviral Therapy
researchProduct

Arquitectura renacentista "inacabada" de Jerónimo Quijano y su integración en determinados templos de origen gòtico

2014

Jerónimo Quijano fue un arquitecto español que destacó durante la etapa del Renacimiento Pleno en España en el tercio central del siglo XVI. Los edificios seleccionados principalmente son: iglesia de Santiago de Orihuela –Alicante– e iglesia de Santa María del Salvador de Chinchilla –Albacete–. En ambos se construyó una nueva cabecera renacentista e integrada en una nave gótica preexistente y en el caso de haber sido “acabadas” íntegramente con el criterio del maestro serían sin duda ejemplos claves del Renacimiento español. En Orihuela se percibe la necesidad de “descubrir” visualmente el magnífico arco de triunfo romano que hace de portada de la nueva cabecera renacentista, sugiriendo así…

Orihuela (Alicante)UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASArquitectura del RenacimientoChinchilla de Montearagón (Albacete):CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]16th centuryJerónimo QuijanoRenaissance Architecture0211-5808 9678 Archivo de arte valenciano 385455 2014 95 4935215 Arquitectura renacentista "inacabada" de Jerónimo Quijano y su integración en determinados templos de origen gòtico López GonzálezAntonio Luis 47 61Siglo XVIMecánica de Medios Continuos y Teoría de Estructuras
researchProduct

Bone Mineral Status in HIV infected Patients in Mediterranean Region: Preliminary Data

2011

Osteoporosis HIV Vitamin DSettore MED/09 - Medicina InternaSettore MED/17 - Malattie InfettiveSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

An international perspective on hospitalized patients with viral community-acquired pneumonia

2019

Background Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the frequency of viral testing, virus prevalence, risk factors and treatment coverage with oseltamivir in patients admitted for CAP. Methods Secondary analysis of GLIMP, an international, multicenter, point-prevalence study of hospitalized adults with CAP. Testing frequency, prevalence of viral CAP and treatment with oseltamivir were assessed among patients who underwent a viral swab. Univariate and multivariate analysis was used to evaluate risk factors. Results 553 (14.9%) patients with CAP underwent nasal swab. Viral CA…

PNEUMONIAMaleMultivariate analysisInternationalityPCV13 pneumococcal conjugate vaccineDatabases FactualHospitalized patientsmedicine.medical_treatmentvirusesCAD coronary artery diseaseTesting030204 cardiovascular system & hematologyMRSA methicillin resistant Staphylococcus aureusPneumònia adquirida a la comunitatRT-PCR reverse transcriptase polymerase chain reactionchemistry.chemical_compound0302 clinical medicineCommunity-acquired pneumoniaTaverne80 and overCommunity-Acquired InfectionViral030212 general & internal medicineProspective StudiesAged 80 and overRIDT rapid influenza diagnostic testCAP community-acquired pneumoniaRSV Respiratory Syncytial virusMiddle AgedICU intensive care unitCommunity-Acquired InfectionsHospitalizationNasal SwabInfectious diseasesFemaleViral swabHumanOseltamivirmedicine.medical_specialtyLogistic ModelCommunity-acquired pneumoniaViral pneumoniaCommunity acquired pneumonia; Influenza; Oseltamivir; Testing; Viral pneumonia; Viral swab; Aged; Aged 80 and over; Antiviral Agents; Community-Acquired Infections; Cross-Sectional Studies; Databases Factual; Female; Hospitalization; Humans; Influenza Human; Internationality; Logistic Models; Male; Medication Adherence; Middle Aged; Oseltamivir; Pneumonia Viral; Prospective StudiesPneumonia ViralAdmissionSettore MED/10 - Malattie Dell'Apparato RespiratorioInfluenzavirusAntiviral AgentsVirusArticleMedication AdherenceHMPV human MetapneumovirusDatabases03 medical and health sciencesLRTI lower respiratory tract infectionOseltamivirInternal medicineInfluenza HumanInternal MedicinemedicineInfluenza virusesHumansHIV Human Immunodeficiency virusPPSV23 pneumococcal polysaccharide vaccineIn patientFactualAgedMechanical ventilationAntiviral AgentCross-Sectional Studiebusiness.industryFEV1 forced expiratory volume in one secondGLIMP global initiative for methicillin-resistant Staphylococcus aureus pneumoniaESBL extended-spectrum beta-lactamasesPneumoniamedicine.diseaseInfluenzaCommunity acquired pneumoniaCI confidence intervalOR odds ratioCross-Sectional StudiesLogistic ModelschemistryCOPD chronic obstructive pulmonary diseasebusinessCommunity acquired pneumonia ; Influenza ; Oseltamivir ; Testing ; Viral pneumonia ; Viral swab
researchProduct

Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.

2020

Abstract Background Throughout the 5000-year history of China, more than 300 epidemics were recorded. Traditional Chinese herbal medicine (TCM) has been used effectively to combat each of these epidemics’ infections, and saved many lives. To date, there are hundreds of herbal TCM formulae developed for the purpose of prevention and treatment during epidemic infections. When COVID-19 ravaged the Wuhan district in China in early January 2020, without a deep understanding about the nature of COVID-19, patients admitted to the TCM Hospital in Wuhan were immediately treated with TCM and reported later with >90% efficacy. Approach We conducted conduct a systematic survey of various TCM herbal pre…

PTGS2 Prostaglandin-endoperoxide synthase 2BattleAIV avian influenza virusCoV coronavirusPharmaceutical ScienceiNOS nitric oxide synthaseViral infection0302 clinical medicinePA patchouli alcoholSARS Severe Acute Respiratory SyndromeSMD Sheganmahuang decoctionDrug DiscoveryPandemicIL InterleukinMedicine Chinese TraditionalALI acute lung injuriesmedia_commonCOVID-19 coronavirus disease 2019MXSG Ma xing shi gan decoction0303 health sciencesTNF tumor necrosis factorClinical Trials as TopicCCL2 CC chemokine ligand 2FM1 FM1 coronavirusICU intensive care unitc-AMP cyclic adenosine phosphateHIV human immunodeficiency virus030220 oncology & carcinogenesisCOX-2 cyclooxygenase-2Molecular MedicineHerbal preparationsMedicinal herbsAbbreviations: ACE2 angiotensin-converting enzyme IITCM traditional Chinese medicineHSV-1 herpes simplex virus 1CASP3 caspase 3medicine.medical_specialtyChinaCoronavirus disease 2019 (COVID-19)Systematic surveymedia_common.quotation_subjectJEV Japanese encephalitis virusNF-κB nuclear factor kappa B cellsAntiviral AgentsArticleWHO World Health Organization03 medical and health sciencesIEC-6 rat intestinal epithelial cell line 6SOD superoxide dismutaseCDC Center for Disease Control and PreventionmedicineAVP arginine vasopressinPGE2 prostaglandin E2HumansIntensive care medicineLH Lianhuaqingwen capsule030304 developmental biologyPharmacologyMedicinal herbMDA malondialdehydeGCGJ Gancao ganjiang decoctionNO nitric oxidePlants Medicinalbusiness.industrySARS-CoV-2COVID-19CXCL C-X-C- motif chemokineMDCK Madin-Darby Canine Kidney cellsTLR-4 Toll-like receptor-4COVID-19 Drug TreatmentComplementary and alternative medicineViral infectionLPS lipopolysaccharidesRSV respiratory syncytial virusQFPD Qingfeipaidu decoctionbusinessLung congestionECMO extracorporeal membrane oxygenationMAPK mitogen-activated protein kinasePhytotherapyDrugs Chinese HerbalPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

PUIG, Isidro; COMPANY, Ximo; TOLOSA, Luisa. "El pintor Joan de Joanes y su entorno familiar. Los Macip a través de las fuentes literarias y la docume…

2016

PUIG Isidro; COMPANY Ximo; TOLOSA Luisa. "El pintor Joan de Joanes y su entorno familiar. Los Macip a través de las fuentes literarias y la documentación de archivo" Artículo ArtículoTOLOSA Luisa. &quotUNESCO::HISTORIA::Historia por especialidades::Historia del artePUIG IsidroEl pintor Joan de Joanes y su entorno familiar. Los Macip a través de las fuentes literarias y la documentación de archivo&quotCOMPANY Ximo:HISTORIA::Historia por especialidades::Historia del arte [UNESCO]
researchProduct

Il palazzo pretorio di Palermo nel XV secolo: nuove fonti archivistiche e iconografiche

2021

This paper aims to trace the original appearance of the Palazzo Pretorio of Palermo, through archival documents and existing iconography referring in particular to before the modifications made according to Giuseppe Damiani Almeyda’s plan in the late nineteenth century. The discovery of new documents and of an unpublished drawing made before the earthquake of 1823, which damaged the structure, has allowed us to further advance the state of knowledge about the edifice and has reduced the level of approximation of the reconstruction hypothesis. In particular, it was possible to have a realistic idea of the conformation of the main facade, originally facing south on the San Cataldo plane, and …

Palazzo Pretorio Palermo Fifteenth Century Archival And Iconographic Sources Reconstruction HypothesisSettore ICAR/18 - Storia Dell'Architettura
researchProduct

Il seicentesco palazzo vescovile di Santa Lucia del Mela (Messina)

2013

The Bishop's Palace in Santa Lucia del Mela (Messina) was built from 1607, commissioned by Don Simone Rao Grimaldi, as prestigious seat for his successors. The riliefs, which are stored in the Archivo General de Simancas, all together with the evaluation of the building and the deed of gift to Filippo III, and the documentary findings due to local scholars, offer the change to consider the constructive issue of a building still less well-known and his "mysterious" architect.

Palazzo vescovile architettura religiosa Simone Rao Grimaldi Santa Lucia del Mela (Messina) Archivo General di Simancas disegni Vincenzo Ferriato (Feriati)Settore ICAR/18 - Storia Dell'Architettura
researchProduct

Un'identità femminile

2018

Il testo illustra la figura di Anna Maria Fundarò, architetto e docente universitaria, fondatrice negli anni '70 della scuola di design dell'Università di Palermo; è strutturato con una breve profilo di A.M. Fundarò e una successiva conversazione a tre voci tra Mario Damiani Almeyda, custode dell' archivio Damiani Almeyda Fundarò, Paola Barbera, storica dell'architettura, Viviana Trapani che oggi insegna Design all'Università di Palermo, diretta dallo studio OMA, curatore della Biennale Nomade d'Arte Contemporanea Manifesta, svoltasi a Palermo nel 2018. Il contributo di V.M. Trapani è centrale nel delineare la rilevanza e l'originalità scientifica e didattica della figura di Anna Maria Fund…

Palermo University Anna Maria Fundarò design education archiveSettore ICAR/13 - Disegno IndustrialeUniversità di Palermo Anna Maria Fundarò didattica del design archivio
researchProduct